Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.2735 (1.26%) ($0.2735 - $0.2735) on Tue. May. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.77% (three month average) | RSI | 36 | Latest Price | $0.2735(1.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.2% a day on average for past five trading days. | Weekly Trend | ANPC declines -6.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) VFMO(93%) VT(92%) IWO(85%) IPO(82%) BLOK(81%) | Factors Impacting ANPC price | ANPC will decline at least -5.385% in a week (0% probabilities). BND(-36%) BNDX(-21%) XLU(-9%) VCIT(3%) VCSH(4%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.385% (StdDev 10.77%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-36.29(-13368.74%) | Resistance Level | $0.36 | 5 Day Moving Average | $0.3(-8.83%) | 10 Day Moving Average | $0.32(-14.53%) | 20 Day Moving Average | $0.36(-24.03%) | To recent high | -68.9% | To recent low | 1.3% | Market Cap | $2m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |